Tag Archives: cardiovascular diseases

Introduction Artificial intelligence (AI) is poised to revolutionise cardiology over the next decade, offering unprecedented potential and exciting advancements. The immense burden of cardiovascular disease in the population provides cardiologists with a huge swathe of rich medical data, yet at the moment this is still underutilised. Machine learning and deep learning are subsets of AI that learn from data, rather than being specifically programmed, to identify new patterns and produce decision-making models.1 From improving diagnostic accuracy to enhancing treatment strategies, machine learning has the power to reshape patient care and outco

Introduction Statins are the gold-standard lipid-lowering therapy based on their efficacy in reducing serum low-density lipoprotein cholesterol (LDL-C) and general tolerability.1 While statins have an extensive body of evidence that have shown them to reduce the risk of cardiovascular (CV) events,2,3 there are concerns around side effects. An increase in cases of treatment-induced comorbidities, such as new-onset diabetes mellitus (NODM) has been observed.4-6 When combined with patient and media concerns, this has led to a reported 50% drop-out rate within 12 months.1 In response, other LDL-C lowering medications have been developed. Proprote

Introduction The incidence of Cutibacterium acnes as the causative organism for infective endocarditis (IE) is reported as 0.3%.1 C. acnes IE is associated with both native and prosthetic valves, but is much more commonly found on prosthetic valves. Studies show that middle-aged men are mostly affected, with serious infections increasingly reported in association with bioprosthetic material.1 C. acnes is part of the commensal flora of the skin, colonising pilous follicles and sebaceous glands, and may also be found in the mucosa of the mouth, nose, urogenital tract and large intestine, this difference might account for the gender-specific b

Introduction Compared with the general population, life-expectancy for people with intellectual disability (ID) is 13 years lower in men and 20 years lower in women.1 Cardiovascular diseases (CVDs) are the leading cause of mortality in ID patients, accounting for 21% of all adult deaths.2 The Dutch Healthy Ageing and Intellectual Disability (HA-ID) study found similar levels of CVD risk in ID patients over 50 years as age-matched controls.3 However, CVDs are significantly underdiagnosed and undermanaged in people with ID. In one study, only 15% of patients with ID who died from CVD had a documented CVD risk assessment.1,2 Assessment of CVD ri

Introduction ACRAN healthcare team Cardiac rehabilitation (CR) services are comprehensive, long-term programmes involving medical evaluation, prescribed exercise, cardiac risk factor modification, education and counselling. CR has been extensively reviewed in the literature,1 and, in patients after myocardial infarction, has been shown to reduce all-cause and cardiovascular mortality rates in a Cochrane review.2 However, it has also been shown by others to have little effect on outcomes.3 Doubts over the efficacy of CR have led commissioners to question the value of such services. While the debate continues, the Anglia region CR services (reb

No content available

No content available